Association of FAM13A polymorphisms with COPD and COPD-related phenotypes in Han Chinese

Clinical Biochemistry

Volumn 46, Issue 16-17, 2013, Pages 1683-1688

  Wang, Bo ^a   Liang, Binmiao ^a   Yang, Jing ^a   Xiao, Jun ^a   Ma, Chunlan ^a   Xu, Sicheng ^a   Lei, Jianbo ^b   Xu, Xuejing ^a   Liao, Zongbing ^a   Liu, Hong ^a   Ou, Xuemei ^a   Feng, Yulin ^a  

^a SICHUAN UNIVERSITY   (China)

^b The People's Hospital of Pengzhou County   (China)

Author keywords

A case control study; Association; Chronic obstructive pulmonary disease; COPD related phenotypes; FAM13A

Indexed keywords

FAM13A PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

A CASE-CONTROL STUDY; ASSOCIATION; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD-RELATED PHENOTYPES; FAM13A;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GTPASE-ACTIVATING PROTEINS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 84886385941     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.07.013     Document Type: Article

References (21)

1. Ezzati M., Lopez A.D. Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362:847-852.
2. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
3. Fletcher C., Peto R., Tinker C., et al. The natural history of chronic bronchitis: an eight year follow up study of working men in London 1976, Oxford University Press, Oxford.
4. Ganrot P.O., Laurell C.B., Eriksson S. Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1967, 19:205-208.
5. Cohen M., Reichenstein M., Everts-van der Wind A., Heon-Lee J., Shani M., Lewin H.A., et al. Cloning and characterization of FAM13A1-a gene near a milk protein QTL on BTA6: evidence for population-wide linkage disequilibrium in Israeli Holsteins. Genomics 2004, 84:374-383.
6. Cho M.H., Boutaoui N., Klanderman B.J., Sylvia J.S., Ziniti J.P., Hersh C.P., et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010, 42:200-202.
7. Pillai S.G., Kong X., Edwards L.D., Cho M.H., Anderson W.H., Coxson H.O., et al. ECLIPSE and ICGN investigators. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182:1498-1505.
8. Hardin M., Zielinski J., Wan E.S., Hersh C.P., Castaldi P.J., Schwinder E., et al. CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland. Am J Respir Cell Mol Biol 2012, 47:203-208.
9. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2011, Global initiative for chronic Obstructive Lung Disease (GOLD), (Updated 2011).
10. Koren-Michowitz M., Shimoni A., Vivante A., Trakhtenbrot L., Rechavi G., Amariglio N., et al. A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res 2008, 32:421-427.
11. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
12. Wilk J.B., Chen T.H., Gottlieb D.J., Walter R.E., Nagle M.W., Brandler B.J., et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009, 5:e1000429.
13. Hancock D.B., Eijgelsheim M., Wilk J.B., Gharib S.A., Loehr L.R., Marciante K.D., et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010, 42:45-52.
14. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
15. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science 1994, 265:2037-2048.
16. Guo Y., Lin H., Gao K., Xu H., Deng X., Zhang Q., et al. Genetic analysis of IREB2, FAM13A and XRCC5 variants in Chinese Han patients with chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2011, 415:284-287.
17. Repapi E., Sayers I., Wain L.V., Burton P.R., Johnson T., Obeidat M., et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010, 42:36-44.
18. Chi J.T., Wang Z., Nuyten D.S., Rodriguez E.H., Schaner M.E., Salim A., et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006, 3:e47.
19. Hersh C.P., Demeo D.L., Lange C., Litonjua A.A., Reilly J.J., Kwiatkowski D., et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33:71-78.
20. Zhou Y.M., Wang C., Yao W.Z., Chen P., Kang J., Huang S.G., et al. A Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China. Zhonghua Nei Ke Za Zhi 2009, 48:358-361.
21. Balding D.J. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006, 7:781-791.